How microencapsulated mineral technology enhances bioavailability, minimises side effects, and improves taste, stability, and format versatility.
As consumers increasingly prioritize proactive wellness, the demand for effective and welltolerated mineral supplementation continues to rise—especially for iron and magnesium, two nutrients essential for daily health and energy metabolism. However, improving bioavailability while reducing common side effects such as gastrointestinal discomfort, metallic aftertaste, precipitation, or reactivity remains a significant formulation challenge.
In this webinar, Lubrizol Nutraceuticals and IMCD will demonstrate a smarter approach: microencapsulated mineral technology designed to significantly improve mineral absorption, reduce sensory and digestive side effects, and unlock broader formulation flexibility across supplements, functional powder beverages, gummies, and other delivery formats.
Webinar highlights
- Overcome key formulation challenges in iron and magnesium, including poor bioavailability and unwanted sensory or digestive side effects.
- Discover how microencapsulation technology enhances mineral absorption while improving taste, stability and tolerability.
- Explore ways to expand iron and magnesium into different delivery formats, from supplements to functional beverages and gummies.
About the speakers
Peter Liu, SEA Business Development Manager, Pharma & Nutra, Lubrizol
Peter has over 20 years of experience in the dietary supplement and functional food industries, spanning across Asia Pacific region. With an education background in pharmacy and market development expertise, Peter has launched several nutraceutical ingredients in the region, developed fruitful B2B collaboration and supported customer’s launch events.
Yolanda Zhu , APAC Technical Manager, Pharma & Nutra, Lubrizol
Yolanda Zhu brings over two decades of expertise in pharmaceutical R&D. With a strong foundation in formulation technologies — spanning solid, semisolid, and liquid dosage forms — she is highly skilled in advanced pharmaceutics and excipient applications. Yolanda is well-versed in FDA and NMPA regulations and has deep experience across the full drug development lifecycle, from project evaluation to manufacturing transfer. She holds a Bachelor’s degree in Pharmacy and Master’s in Pharmaceutical Engineering, and previously held leadership roles at France Ethypharm and Fosun Pharma group.
Do you want to read the full article?
Full access also means:
